Global Combination Antibody Therapy Market Size, Share, and COVID-19 Impact Analysis, By Type (Antibody/Antibody, Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies, Others), By End-Users (Hospitals, Homecare, Speciality Centres, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jul 2025
REPORT ID SI13393
PAGES 269
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By End-Users
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. The growing prevalence of cancer and developed healthcare infrastructure
    3. Restraints
      1.  Strict adherence to regulations delay progress and high upfront cost
    4. Opportunities
      1. Ongoing research in novel infrastructure with substantial investment
    5. Challenges

5.5.1.     Potential side effects and complexity during integration

  1. Global Combination Antibody Therapy Market Analysis and Projection, By Type
    1. Segment Overview
    2. Antibody/Antibody
    3. Antibody-Drug Conjugates
    4. Bispecific Antibodies
    5. Chemotherapy-Monoclonal Antibodies
    6. Others
  2. Global Combination Antibody Therapy Market Analysis and Projection, By End-Users
    1. Segment Overview
    2. Hospitals
    3. Homecare
    4. Speciality Centres
    5. Others
  3. Global Combination Antibody Therapy Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Combination Antibody Therapy Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Combination Antibody Therapy Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. F. Hoffmann-La Roche Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Mylan N.V. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Pfizer Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   GSK plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Lilly
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Merck & Co., Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Sun Pharmaceutical Industries Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Teva Pharmaceutical Industries Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Seagen Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  CELGENE CORPORATION 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Genmab A/S
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  2. Global Antibody/Antibody, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  3. Global Antibody-Drug Conjugates, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  4. Global Bispecific Antibodies, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  5. Global Chemotherapy-Monoclonal Antibodies, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  6. Global Others, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  7. Global Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  8. Global Hospitals, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  9. Global Homecare, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  10. Global Speciality Centres, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  11. Global Others, Combination Antibody Therapy Market, By Region, 2024-2035(USD Billion)
  12. North America Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  13. North America Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  14. U.S.  Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  15. U.S.  Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  16. Canada Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  17. Canada Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  18. Mexico Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  19. Mexico Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  20. Europe Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  21. Europe Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  22. Germany Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  23. Germany Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  24. France Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  25. France Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  26. U.K.  Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  27. U.K.  Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  28. Italy Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  29. Italy Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  30. Spain Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  31. Spain Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  32. Asia Pacific Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  33. Asia Pacific Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  34. Japan Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  35. Japan Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  36. China Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  37. China Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  38. India Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  39. India Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  40. South America Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  41. South America Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  42. Brazil Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  43. Brazil Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  44. The Middle East and Africa Combination Antibody Therapy Market, By Type, 2024-2035(USD   Billion)
  45. The Middle East and Africa Combination Antibody Therapy Market, By End-Users, 2024-2035(USD   Billion)
  46. UAE Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  47. UAE Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)
  48. South Africa Combination Antibody Therapy Market, By Type, 2024-2035(USD Billion)
  49. South Africa Combination Antibody Therapy Market, By End-Users, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Combination Antibody Therapy Market Segmentation
  2. Combination Antibody Therapy Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Combination Antibody Therapy Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Combination Antibody Therapy Market
  20. Combination Antibody Therapy Market Segmentation, By Type
  21. Combination Antibody Therapy Market For Antibody/Antibody, By Region, 2024-2035 ($ Billion)
  22.  Combination Antibody Therapy Market For Antibody-Drug Conjugates, By Region, 2024-2035 ($ Billion)
  23. Combination Antibody Therapy Market For Bispecific Antibodies, By Region, 2024-2035 ($ Billion)
  24. Combination Antibody Therapy Market For Chemotherapy-Monoclonal Antibodies, By Region, 2024-2035 ($ Billion)
  25. Combination Antibody Therapy Market For Others, By Region, 2024-2035 ($ Billion)
  26.  Combination Antibody Therapy Market Segmentation, By End-Users
  27.  Combination Antibody Therapy Market For Hospitals, By Region, 2024-2035 ($ Billion)
  28.  Combination Antibody Therapy Market For Homecare, By Region, 2024-2035 ($ Billion)
  29. Combination Antibody Therapy Market For Speciality Centres, By Region, 2024-2035 ($ Billion)
  30. Combination Antibody Therapy Market For Others, By Region, 2024-2035 ($ Billion)
  31. F. Hoffmann-La Roche Ltd.: Net Sales, 2024-2035 ($ Billion)
  32. F. Hoffmann-La Roche Ltd.: Revenue Share, By Segment, 2024 (%)
  33. F. Hoffmann-La Roche Ltd.: Revenue Share, By Region, 2024 (%)
  34. Mylan N.V.: Net Sales, 2024-2035 ($ Billion)
  35. Mylan N.V.: Revenue Share, By Segment, 2024 (%)
  36. Mylan N.V.: Revenue Share, By Region, 2024 (%)
  37. Sanofi: Net Sales, 2024-2035 ($ Billion)
  38. Sanofi: Revenue Share, By Segment, 2024 (%)
  39. Sanofi: Revenue Share, By Region, 2024 (%)
  40. Pfizer Inc.: Net Sales, 2024-2035 ($ Billion)
  41. Pfizer Inc.: Revenue Share, By Segment, 2024 (%)
  42. Pfizer Inc.: Revenue Share, By Region, 2024 (%)
  43. GSK plc: Net Sales, 2024-2035 ($ Billion)
  44. GSK plc: Revenue Share, By Segment, 2024 (%)
  45. GSK plc: Revenue Share, By Region, 2024 (%)
  46. Novartis AG: Net Sales, 2024-2035 ($ Billion)
  47. Novartis AG: Revenue Share, By Segment, 2024 (%)
  48. Novartis AG: Revenue Share, By Region, 2024 (%)
  49. Bayer AG: Net Sales, 2024-2035 ($ Billion)
  50. Bayer AG: Revenue Share, By Segment, 2024 (%)
  51. Bayer AG: Revenue Share, By Region, 2024 (%)
  52. Lilly: Net Sales, 2024-2035 ($ Billion)
  53. Lilly: Revenue Share, By Segment, 2024 (%)
  54. Lilly: Revenue Share, By Region, 2024 (%)
  55. Merck & Co., Inc..: Net Sales, 2024-2035 ($ Billion)
  56. Merck & Co., Inc..: Revenue Share, By Segment, 2024 (%)
  57. Merck & Co., Inc..: Revenue Share, By Region, 2024 (%)
  58. Sun Pharmaceutical Industries Ltd.: Net Sales, 2024-2035 ($ Billion)
  59. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  60. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  61. Teva Pharmaceutical Industries Ltd: Net Sales, 2024-2035 ($ Billion)
  62. Teva Pharmaceutical Industries Ltd: Revenue Share, By Segment, 2024 (%)
  63. Teva Pharmaceutical Industries Ltd: Revenue Share, By Region, 2024 (%)
  64. Seagen Inc.: Net Sales, 2024-2035 ($ Billion)
  65. Seagen Inc.: Revenue Share, By Segment, 2024 (%)
  66. Seagen Inc.: Revenue Share, By Region, 2024 (%)
  67. CELGENE CORPORATION: Net Sales, 2024-2035 ($ Billion)
  68. CELGENE CORPORATION: Revenue Share, By Segment, 2024 (%)
  69. CELGENE CORPORATION: Revenue Share, By Region, 2024 (%)
  70. Genmab A/S: Net Sales, 2024-2035 ($ Billion)
  71. Genmab A/S: Revenue Share, By Segment, 2024 (%)
  72. Genmab A/S: Revenue Share, By Region, 2024 (%)
  73. Others: Net Sales, 2024-2035 ($ Billion)
  74. Others: Revenue Share, By Segment, 2024 (%)
  75. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:128
Pages:269
Countries covered:21
Companies covered::18
Forecast CAGR:8.95%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies